Julie Rayes

Has grant

Associate Professor & British Heart Foundation intermediate fellow

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Julie Rayes is an Associate Professor and British Heart Foundation intermediate fellow at the University of Birmingham, UK. Her research focuses on immune dynamics in cardiac injury and disease, thrombosis, and platelet dysfunction as evidenced by her recent publications. She has contributed significantly to the understanding of organoids in disease modeling and the effects of inflammatory processes on thrombogenesis.

Recent Grants

Grant: Close

Role of platelet ITAM receptors in thrombo-inflammation

Open Date: 2019-08-01

Close Date: 2021-02-01

Grant: Close

Development of novel ex-vivo models of thrombo-inflammation to investigate platelet-immune cell interactions

Open Date:

Close Date:

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (20)

Asif Iqbal

University of Birmingham

UNITED KINGDOM

Julie Rayes

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Human Multi-Organoid Platform to Model Immune Dynamics in Cardiac Injury and Disease

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice.

Platelet-specific SLFN14 deletion causes macrothrombocytopenia and platelet dysfunction through dysregulated megakaryocyte and platelet gene expression.

Discrete and conserved inflammatory signatures drive thrombosis in different organs after Salmonella infection.

Generating human bone marrow organoids for disease modeling and drug discovery

Hot under the clot: venous thrombogenesis is an inflammatory process

PITX2 deficiency leads to atrial mitochondrial dysfunction.

Hydroxychloroquine inhibits hemolysis-induced arterial thrombosis ex vivo and improves lung perfusion in hemin-treated mice.

High factor VIII concentrations interfere with glycoprotein VI-mediated platelet activation in vitro.

Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in Von Willebrand disease murine models

Basic Mechanisms of Hemolysis-Associated Thrombo-Inflammation and Immune Dysregulation

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.

Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues.

SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation

S100A8/A9 drives the formation of procoagulant platelets through GPIbα.

CLEC-2 supports platelet aggregation in mouse but not human blood at arterial shear.

Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature

Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.

Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation.

Platelet‐inspired nanomedicine in hemostasis thrombosis and thromboinflammation

Collaborators (20)

Asif Iqbal

Megan Simpson

Natalie J. Jooss

Samantha Montague

Adam Croft

Frédéric ADAM

Max Crispin

Bethan Psaila

Alexander Brill

Harriet Hill

Joanne Clark

Alexandre Slater

Christopher Barrett

Peter J. Lenting

Elena Barbon

Joshua Price

Ejaife Ono Agbani

Kellie Machlus

Edith Marcial-Juárez

Sönke Harder

Make your next move.